In a report released today, Michael Higgins from Ladenburg Thalmann & Co. maintained a Buy rating on Viridian Therapeutics (VRDN), with a price ...
The post Viridian Therapeutics (VRDN) Receives a Buy from Ladenburg Thalmann & Co. appeared first on Smarter Analyst.
In a report released today, ...

https://www.smarteranalyst.com/new-blurbs/viridian-therapeutics-vrdn-receives-a-buy-from-ladenburg-thalmann-co/

#SmarterAnalyst